Arch Oncology competitorsClear all

Priothera's top competitors include Tollys.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Priothera
Priothera
Priothera is a company that develops receptor modulators intended to improve the lives of patients suffering from hematological malignancies.
Tollys
Tollys
Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor.
Founding Date
Founding Date
2020
Founding Date
2015
Type
Type
Private
Type
Private
Tags
Locations
Locations
Dublin, IE HQ
Locations
Lyon, FR HQ
Lyon, FR
Employees
Employees
N/A
Employees
N/A

Funding

Latest funding round
Latest funding round
$ 35.5m (over 1 year ago)
Latest funding round
$ 2.5m (about 2 years ago)
Total funding raised
Total funding raised
$ 35.5m
Total funding raised
$ 6.8m
For sources of this data, please see the company profile

View company profiles

Tollys
HQ
Lyon, FR

Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor.

View company